Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04409262
Brief Title: A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia (REMDACTA)

First Submitted : May 28, 2020
First Submitted that Met QC Criteria : May 28, 2020
First Posted : June 1, 2020

Last Update Submitted that Met QC Criteria : March 9, 2021
Last Update Posted : March 11, 2021